Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Conroy

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 3, 2022
A single centre 20-year retrospective cohort study: Percutaneous endoscopic colostomyNicholas Farkas, Ross Kenny, Michael Conroy, et al.
The Journal of Investigative Dermatology|March 2, 2005
Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphomaEric C Vonderheid, Christine M Boselli, Michael Conroy, et al.
Journal for Immunotherapy of Cancer|February 11, 2021
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancerKaren Slattery, Elena Woods, Vanessa Zaiatz-Bittencourt, et al.
JCO Precision Oncology|July 1, 2026
Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board DiscussionIlias Ziakas, Amna Jamali, Michael Conroy, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
BMC Cancer|August 7, 2025
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicityRonan Andrew McLaughlin, David McMahon, Christopher Cluxton, et al.
BMJ Open|October 8, 2020
Patient characteristics associated with a poor response to non-surgical multidisciplinary management of knee osteoarthritis: a multisite prospective longitudinal study in an advanced practice physiotherapist-led tertiary serviceShaun O'Leary, Maree Raymer, Peter Window, et al.
Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stabilityYujie Zhao, Jarushka Naidoo, Michael Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 3, 2022
A single centre 20-year retrospective cohort study: Percutaneous endoscopic colostomyNicholas Farkas, Ross Kenny, Michael Conroy, et al.
The Journal of Investigative Dermatology|March 2, 2005
Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphomaEric C Vonderheid, Christine M Boselli, Michael Conroy, et al.
Journal for Immunotherapy of Cancer|February 11, 2021
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancerKaren Slattery, Elena Woods, Vanessa Zaiatz-Bittencourt, et al.
JCO Precision Oncology|July 1, 2026
Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board DiscussionIlias Ziakas, Amna Jamali, Michael Conroy, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
BMC Cancer|August 7, 2025
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicityRonan Andrew McLaughlin, David McMahon, Christopher Cluxton, et al.
BMJ Open|October 8, 2020
Patient characteristics associated with a poor response to non-surgical multidisciplinary management of knee osteoarthritis: a multisite prospective longitudinal study in an advanced practice physiotherapist-led tertiary serviceShaun O'Leary, Maree Raymer, Peter Window, et al.
Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stabilityYujie Zhao, Jarushka Naidoo, Michael Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Pageof 4